Evaluating the Cavitary Lung Lesions on CT Scan of COVID-19 Patients: A Retrospective Study.

Golnaz Moradi, Safa S Etehadi, Seyed H Mousavi, Rayeheh Mohammadi
Author Information
  1. Golnaz Moradi: Department of Radiology, Sina Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  2. Safa S Etehadi: Tehran University of Medical Sciences, Tehran, Iran.
  3. Seyed H Mousavi: Department of Urology, Tehran University of Medical Sciences, Tehran, Iran.
  4. Rayeheh Mohammadi: Department of Radiology, Sina Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Abstract

Background: It has been shown that cavitary lesions on CT scans of patients with COVID-19 may be related to their clinical symptoms and mortality rate.
Materials and methods: The study population included patients diagnosed with COVID-19 based on RT-PCR results from throat samples or typical clinical and chest CT scan findings who were hospitalized at Sina Hospital in Tehran in 2020 and underwent chest CT scans. Chest CT scans were examined for the severity of pulmonary opacities and the presence, number, size, wall thickness, and distribution of cavitary lung lesions.
Results: Oxygen saturation was lower in patients with cavitary lesions in the initial state and after treatment than those without cavitation, and a statistically significant relationship was observed (p < 0.05). In terms of gender, a significant correlation was observed, and the prevalence of cavitary lesions was higher in men (p < 0.05). Also, the in-hospital mortality rate was higher in patients with cavitary lesions (p < 0.05).
Conclusion: Based on our results, the presence of cavitary lung lesions in COVID-19 patients is related to the mortality rate, severity of pulmonary involvement, and patients' gender.

Keywords

References

  1. Radiology. 2022 Jan;302(1):214-217 [PMID: 34463553]
  2. Zhonghua Bing Li Xue Za Zhi. 2020 May 8;49(5):411-417 [PMID: 32172546]
  3. Eur Radiol. 2021 Jul;31(7):5178-5188 [PMID: 33449185]
  4. Expert Rev Mol Diagn. 2020 May;20(5):453-454 [PMID: 32297805]
  5. Invest Radiol. 2020 Jun;55(6):327-331 [PMID: 32118615]
  6. Int J Community Wellbeing. 2021;4(3):339-343 [PMID: 34723124]
  7. Sci Rep. 2021 Aug 6;11(1):16039 [PMID: 34362979]
  8. Biosens Bioelectron. 2020 Oct 15;166:112455 [PMID: 32739797]
  9. HCA Healthc J Med. 2020 Nov 28;1:365-368 [PMID: 37426844]
  10. Clin Immunol. 2020 Jun;215:108427 [PMID: 32325252]
  11. Crit Care. 2020 Jun 18;24(1):360 [PMID: 32552865]
  12. Signal Transduct Target Ther. 2020 Jul 25;5(1):128 [PMID: 32712629]
  13. J Cardiovasc Transl Res. 2023 Aug;16(4):852-861 [PMID: 36932263]
  14. Eur Radiol. 2020 Sep;30(9):4865-4873 [PMID: 32291502]
  15. Diagn Interv Radiol. 2020 Jul;26(4):380-381 [PMID: 32436846]
  16. BMJ Case Rep. 2020 Sep 7;13(9): [PMID: 32900753]
  17. Postgrad Med J. 2021 Aug;97(1150):521-531 [PMID: 32934178]
  18. Immun Inflamm Dis. 2023 Nov;11(11):e1090 [PMID: 38018577]
  19. Histopathology. 2020 Aug;77(2):198-209 [PMID: 32364264]
  20. BMC Pulm Med. 2021 Jan 12;21(1):24 [PMID: 33435949]
  21. BMJ Case Rep. 2020 Jul 6;13(7): [PMID: 32636231]
  22. Interact Cardiovasc Thorac Surg. 2021 Jan 1;32(1):150-152 [PMID: 33332525]
  23. Iran J Pharm Res. 2021 Summer;20(3):399-418 [PMID: 34903997]
  24. Radiat Phys Chem Oxf Engl 1993. 2023 Apr;205:110739 [PMID: 36567703]

Word Cloud

Created with Highcharts 10.0.0cavitarylesionsCTpatientsCOVID-19scansmortalityratep<005relatedclinicalresultschestscanseveritypulmonarypresencelungsignificantobservedgenderhigherCavitaryBackground:shownmaysymptomsMaterialsmethods:studypopulationincludeddiagnosedbasedRT-PCRthroatsamplestypicalfindingshospitalizedSinaHospitalTehran2020underwentChestexaminedopacitiesnumbersizewallthicknessdistributionResults:OxygensaturationlowerinitialstatetreatmentwithoutcavitationstatisticallyrelationshiptermscorrelationprevalencemenAlsoin-hospitalConclusion:Basedinvolvementpatients'EvaluatingLungLesionsScanPatients:RetrospectiveStudylesion

Similar Articles

Cited By